How severe is CVE-2024-2276?

CVE-2024-2276 has a CVSS 3.x base score of 2.4, rated low severity. It is exploitable over network with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.

Is CVE-2024-2276 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (38th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2024-2276?

CVE-2024-2276 affects Bdtask G-prescription Gynaecology & Obs Consultation. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2024-2276?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2024-2276 have an EU (EUVD) identifier?

Yes. CVE-2024-2276 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-27231.

When was CVE-2024-2276 published?

CVE-2024-2276 was published on 2024-03-08 and last updated on 2026-06-17.

CVE-2024-2276

CVE-2024-2276 is a low-severity vulnerability in Bdtask G-prescription Gynaecology & Obs Consultation with a CVSS 3.x base score of 2.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Low (CVSS 3.x base score 2.4)
CVSS v2: 3.3
EPSS exploit prediction: 0% (38th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-27231
Weakness: CWE-79
Affected product: Bdtask G-prescription Gynaecology & Obs Consultation
Published: 2024-03-08
Last modified: 2026-06-17

Description

A vulnerability has been found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0 and classified as problematic. Affected by this vulnerability is an unknown functionality of the file /Venue_controller/edit_venue/ of the component Edit Venue Page. The manipulation of the argument Venue map leads to cross site scripting. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-256045 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Frequently asked questions

What is CVE-2024-2276?: A vulnerability has been found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0 and classified as problematic. Affected by this vulnerability is an unknown functionality of the file /Venue_controller/edit_venue/ of the component Edit Venue Page. The manipulation of the argument Venue map leads to cross site scripting. The attack can be launched remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-256045 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
How severe is CVE-2024-2276?: CVE-2024-2276 has a CVSS 3.x base score of 2.4, rated low severity. It is exploitable over network with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.
Is CVE-2024-2276 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (38th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-2276?: CVE-2024-2276 affects Bdtask G-prescription Gynaecology & Obs Consultation. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-2276?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-2276 have an EU (EUVD) identifier?: Yes. CVE-2024-2276 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-27231.
When was CVE-2024-2276 published?: CVE-2024-2276 was published on 2024-03-08 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:bdtask:g-prescription_gynaecology_\&_obs_consultation:1.0:*:*:*:*:*:*:*

More vulnerabilities in Bdtask G-prescription Gynaecology & Obs Consultation

CVE-2024-2277 — Medium (CVSS 4.3): A vulnerability was found in Bdtask G-Prescription Gynaecology & OBS Consultation Software 1.0 and classified as…
CVE-2024-2275 — Low (CVSS 2.4): A vulnerability, which was classified as problematic, was found in Bdtask G-Prescription Gynaecology & OBS Consultation…
CVE-2024-2274 — Low (CVSS 2.4): A vulnerability, which was classified as problematic, has been found in Bdtask G-Prescription Gynaecology & OBS…

All CVEs affecting Bdtask G-prescription Gynaecology & Obs Consultation →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →